Compounding Expensive FDA-Approved Drugs to Reduce Price: Potential Challenge to the 505(b)(2) or Generic Pathway
If your prescription drug is too expensive, can you simply buy a compounded drug to get a cheaper version? And if this goes forward, does it not create a challenge for all developers of 505(b)(2) or even generic drugs? What about expanding this logic to the very expensive biological drugs? Would FDA allow that? The … Read more